Malte Lenders - Concepedia

Author

Malte Lenders

University Hospital Münster ORCID

Also Known As

Lenders, Malte, M B Lenders, M. Lenders, Malte Lenders

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University Hospital Münster Charité - Universitätsmedizin Berlin University of Würzburg University of Münster Johannes Gutenberg University Mainz

About

Malte Lenders is an author at University Hospital Münster specializing in medicine, pathology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	269
2	Natural Sciences	3	3	48
3	Biochemistry	3	3	48
4	Engineering	2	2	106
5	Public Health	1	1	47

Malte Lenders

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease Malte Lenders, Jörg Stypmann, Thomas Duning, Journal of the American Society of Nephrology Heart FailureEnzyme Replacement TherapyPathologyNephrologyFd Benefit	2015	126
Characterization of rubber particles and rubber chain elongation in Taraxacum koksaghyz Thomas J. Schmidt, Malte Lenders, Andrea Hillebrand, BMC Biochemistry	2010	120
Down-Regulation of Small Rubber Particle Protein Expression Affects Integrity of Rubber Particles and Rubber Content in Taraxacum brevicorniculatum Andrea Hillebrand, Janina Post, David Wurbs, PLoS ONE	2012	100
Molecular Cloning and Characterization of Rubber Biosynthetic Genes from Taraxacum koksaghyz Thomas J. Schmidt, Andrea Hillebrand, David Wurbs, Plant Molecular Biology Reporter BiologyBiosynthesisEngineeringTaraxacum KoksaghyzRubber Biosynthetic Genes	2009	86
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease Malte Lenders, Leon Paul Neußer, Michael Rudnicki, Journal of the American Society of Nephrology	2018	72
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch Frank Weidemann, Johannes Krämer, Thomas Duning, Journal of the American Society of Nephrology	2014	68
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS) Malte Lenders, Peter Nordbeck, Christine Kurschat, Clinical Pharmacology & Therapeutics	2020	65
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant Malte Lenders, Frank Weidemann, Christine Kurschat, Orphanet Journal of Rare Diseases	2016	64
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease Sanne J. van der Veen, Wytze J. Vlietstra, Laura van Dussen, International Journal of Molecular Sciences	2020	61
Treatment of Fabry Disease management with migalastat—outcome from a prospective 24 months observational multicenter study (FAMOUS) Malte Lenders, Peter Nordbeck, Christine Kurschat, European Heart Journal - Cardiovascular Pharmacotherapy	2021	59

Page 1